| |
| |
|
| Insider
Information: |
Schnell David |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
8,316 |
|
|
Indirect Shares
|
15,131,991 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$7,584,502 |
|
|
| Total
Shares |
15,140,307 |
|
|
| Total
Value |
$7,584,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Senomyx Inc |
SNMX |
Director |
2006-02-09 |
8,316 |
2006-02-09 |
363,197 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
10% Owner |
|
0 |
2006-09-12 |
2,102,398 |
Premium* |
|
|
Trubion Pharmaceuticals, Inc |
TRBN |
Director |
2006-10-17 |
0 |
2010-10-28 |
27,866 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
10% Owner |
2007-05-30 |
0 |
2007-05-30 |
34,312 |
Premium* |
|
|
Kythera Biopharmaceuticals Inc |
KYTH |
Director, 10% Owner |
2012-10-16 |
0 |
2012-10-16 |
1,914,566 |
Premium* |
|
|
Trans1 Inc |
TSON |
10% Owner |
|
0 |
2013-05-31 |
5,340,616 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
|
0 |
2015-03-24 |
424,036 |
Premium* |
|
|
Ngm Biopharmaceuticals Inc |
NGM |
Director |
2019-04-08 |
0 |
2019-04-08 |
4,925,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGM |
Ngm Biopharmaceuticals In... |
Director |
– • – |
2019-04-08 |
4 |
A |
$0.00 |
$0 |
I/I |
4,925,000 |
4,925,000 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
10% Owner |
– – • |
2015-03-24 |
4 |
A |
$0.00 |
$0 |
I/I |
40,714 |
28,237 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
10% Owner |
– – • |
2015-03-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(900,383) |
1,672,140 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
10% Owner |
– – • |
2014-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
126,082 |
|
- |
|
| TSON |
Trans1 Inc |
10% Owner |
– – • |
2013-05-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,340,616 |
|
- |
|
| KYTH |
Kythera Biopharmaceutical... |
Director |
– • • |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,914,566 |
1,914,566 |
0 |
- |
|
| TRBN |
Trubion Pharmaceuticals, ... |
Director |
– • – |
2010-10-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,857,631) |
27,866 |
0 |
- |
|
| HNSN |
Hansen Medical Inc |
10% Owner |
– – • |
2007-05-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(355,330) |
34,312 |
0 |
- |
|
| TRBN |
Trubion Pharmaceuticals, ... |
Director |
– • – |
2006-10-17 |
4 |
B |
$13.00 |
$457,353 |
I/I |
35,181 |
27,866 |
2.1 |
- |
|
| TRBN |
Trubion Pharmaceuticals, ... |
Director |
– • – |
2006-10-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,822,450 |
27,338 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
10% Owner |
– – • |
2006-09-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,102,398 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2006-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,816 |
8,316 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2006-02-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(363,198) |
363,197 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
6,500 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-08-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(300,000) |
726,395 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-06-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(200,000) |
1,026,395 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
5,000 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
4,000 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-05-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(300,000) |
1,226,395 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2005-03-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(500,000) |
1,526,395 |
|
- |
|
| SNMX |
Senomyx Inc |
Director |
– • – |
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
2,026,395 |
2,026,395 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
